• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SUN Haiyan.Analysis of aspirin related gout and hyperuricaemia adverse events based on FDA adverse event database[J].Journal Of Pharmaceutical Research,2022,41(12):838-840[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2421times   Download 2289次 QR Code for this article
Scan with your phone!
基于FDA不良事件数据库阿司匹林相关痛风和高尿酸血症不良事件分析
孙海燕
Font:Larger+|Default|Smaller-
(烟台毓璜顶医院,山东 烟台 264000)
摘要:
目的 利用美国食品药品监督管理局(FDA)不良事件报告系统(FAERS)数据库挖掘阿司匹林相关痛风和高尿酸血症的不良事件(AE)信号并进行分析,为其临床安全合理用药提供参考。方法 采用报告比值比(ROR)法对美国食品药品监督管理局公共数据开放项目OpenVigil 2.1数据库中于2004年1月1日-2021年9月30日上报的阿司匹林相关的痛风和高尿酸血症不良事件进行数据挖掘。结果 阿司匹林相关痛风的不良事件报告数为625 例,报告比值比的 95%CI:3.254 (2.997-3.533)。高尿酸血症90个,报告比值比的 95%CI:2.464 (1.989-3.053)。女性信号强度高于男性,18~44岁年龄组信号强度高于其他年龄组。痛风和高尿酸血症不良事件中应用的阿司匹林均为小剂量。结论 小剂量阿司匹林是诱发痛风和高尿酸血症风险信号,阿司匹林诱发痛风信号强度高于高尿酸血症,二者可能为2个独立的不良事件,无相关性。女性和18~44岁组服用小剂量阿司匹林应低嘌呤饮食,注意监测血尿酸和痛风发作。
关键词:  阿司匹林  美国食品药品监督管理局不良事件报告系统  痛风  高尿酸血症  信号挖掘
DOI:10.13506/j.cnki.jpr.2022.12.014
基金项目:烟台市科技计划(No.2020YD027)
Publication Date:December 25, 2022
Analysis of aspirin related gout and hyperuricaemia adverse events based on FDA adverse event database
SUN Haiyan
(Yantai Yuhuangding Hospital,Yantai 264000,China)
Abstract:
Objective The adverse events(AE) signals of aspirin related gout and hyperuricaemia were mined and analyzed by using the FDA adverse event reporting system (FAERS) database, so as to provide reference for clinical safe and rational drug use. Methods The reported odds ratio (ROR) method was used to mine the AE of gout and hyperuricaemia of aspirin reported in the open FDA OpenVigil 2.1 database from January 1, 2004 to September 30, 2021. Results The number of AE reported for aspirin associated gout was 625, with a 95% CI of ROR:3.254 (2.997-3.533) and hyperuricaemia was 90, with a 95%CI of ROR: 2.464 (1.989-3.053). The signal intensity of female is higher than that of male, and that of 18-44 age group is higher than that of other age groups. Aspirin used in AE was low-dose.Conclusion Low dose aspirin is the risk signal of gout and hyperuricaemia. The signal intensity of gout is higher than that of hyperuricaemia. There is no correlation between them as independent AE . The female and 18-44 years old group taking low dose aspirin should take low purine diet, and pay attention to monitoring blood uric acid and gout attack.
Key words:  Aspirin  FDA adverse event reporting system  Gout  Hyperuricaemia  Signal mining
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.